NCT02789956

Brief Summary

The aim of this study is to evaluate: Primary objective The primary objective of the present study is to evaluate the marginal bone level changes when partially edentulous patients, treated with implants, received a multiunits screw retained fixed dental prosthesis with a Co/Cr milled framework with an Internal or External connection. Secondary objective

  1. 1.Overall survival rate.
  2. 2.Soft tissue status by assessment of bleeding on probing (BoP) and probing pocket depth (PPD) at baseline and after 1,3,5 years.
  3. 3.Prosthetic survival rates including screw or abutment loosening, framework or veneer fractures.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 3, 2016

Completed
28 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

February 5, 2025

Status Verified

February 1, 2025

Enrollment Period

8.2 years

First QC Date

May 29, 2016

Last Update Submit

February 1, 2025

Conditions

Keywords

Internal connectionCobalt/ChromeCad-cam Frameworkmarginal bone level

Outcome Measures

Primary Outcomes (3)

  • Marginal bone resorption in millimeter from the implant to the bone crest.

    1 year

  • Marginal bone resorption in millimeter from the implant to the bone crest.

    3 year

  • Marginal bone resorption in millimeter from the implant to the bone crest.

    5 year

Secondary Outcomes (3)

  • Fracture of the prosthetic components

    1 year

  • Fracture of the prosthetic components

    3 year

  • Fracture of the prosthetic components

    5 year

Study Arms (2)

Test: internal connection

EXPERIMENTAL

Evaluate marginal bone level (MBL) changes at implants that are placed semi-edentulous patient when they are treated with implant level Co/cr Cad/Cam framework.

Device: Internal vs. external cad cam co/cr framework

Test: external connection

ACTIVE COMPARATOR

Evaluate marginal bone level (MBL) changes at implants that are placed semi-edentulous patient when they are treated with abutment level Co/cr Cad/Cam framework.

Device: Internal vs. external cad cam co/cr framework

Interventions

Also known as: Astratech EV system, Dentsply HI
Test: external connectionTest: internal connection

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years.
  • Willingness to comply with all study requirements and to sign the IC.
  • Systemic health.
  • Compliance with good oral hygiene.
  • Patients with at least 2 teeth to replace in any side of the jaws.

You may not qualify if:

  • Patients treated with implant with bone defects associated with severe knife-edge ridges.
  • Patients treated with bone defects resulting from tumor resection.
  • Tobacco abuse (\> 10 cigarettes/day).
  • Severe renal and liver disease.
  • History of radiotherapy in the head and neck region.
  • Chemotherapy for treatment of malignant tumors at the time of the surgical procedure.
  • Uncontrolled diabetes.
  • Active periodontal disease involving the residual opposite dentition.
  • Mucosal disease, such as lichen planus, in the areas to be treated.
  • Poor oral hygiene.
  • Non-compliant patients.
  • Situations judged inconvenient(by the investigator) for the surgical treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Studiotoia Srl

Busto Arsizio, Varese, 21052, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr

Study Record Dates

First Submitted

May 29, 2016

First Posted

June 3, 2016

Study Start

July 1, 2016

Primary Completion

September 1, 2024

Study Completion

September 1, 2025

Last Updated

February 5, 2025

Record last verified: 2025-02

Locations